Core Viewpoint - Elanco Animal Health has received emergency use authorization from the U.S. Food and Drug Administration for its flea and tick drug aimed at treating dogs infected with a flesh-eating parasite [1] Company Summary - Elanco Animal Health is expanding its product offerings with the new flea and tick drug, which is designed to address a significant health issue in dogs [1] Industry Summary - The approval from the FDA highlights the ongoing need for effective treatments in the veterinary pharmaceutical industry, particularly for parasitic infections in pets [1]